<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(1)</volume><submitter>Ortega C</submitter><pubmed_abstract>Rubella virus (RV) IgG quantification is essential for verifying immunity, particularly in prenatal care. However, substantial variability exists among commercial immunoassays, especially when testing low-antibody sera. In this study, we evaluated five commercial assays-four chemiluminescent immunoassays (CLIAs) and one Enzyme-linked Immunosorbent Assay (ELISA)-using a recombinant immunoblot (IB) as the reference method. A panel of 137 serum samples with low or undetectable IgG levels was analyzed. Sensitivity ranged from 19.6% to 70.1%, while specificity exceeded 94%. Only 18.6% of immunoblot-positive samples tested positive across all assays. Marked quantitative differences were observed, with the Atellica assay yielding the highest titers and Alinity the lowest. Reclassifying equivocal </pubmed_abstract><journal>Microorganisms</journal><pagination>58</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12844522</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Evaluation of Commercial Immunoassays for Rubella Virus IgG Detection in Low-Antibody Sera Using a Recombinant Immunoblot as a Reference Method.</pubmed_title><pmcid>PMC12844522</pmcid><pubmed_authors>Reguera JA</pubmed_authors><pubmed_authors>Rodriguez-Granger J</pubmed_authors><pubmed_authors>Cobo F</pubmed_authors><pubmed_authors>Abreu A</pubmed_authors><pubmed_authors>Ortega C</pubmed_authors><pubmed_authors>Sampedro-Padilla A</pubmed_authors><pubmed_authors>Sampedro A</pubmed_authors><pubmed_authors>Serrano J</pubmed_authors><pubmed_authors>Gutierrez-Bautista JF</pubmed_authors><pubmed_authors>Mazuelas P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Evaluation of Commercial Immunoassays for Rubella Virus IgG Detection in Low-Antibody Sera Using a Recombinant Immunoblot as a Reference Method.</name><description>Rubella virus (RV) IgG quantification is essential for verifying immunity, particularly in prenatal care. However, substantial variability exists among commercial immunoassays, especially when testing low-antibody sera. In this study, we evaluated five commercial assays-four chemiluminescent immunoassays (CLIAs) and one Enzyme-linked Immunosorbent Assay (ELISA)-using a recombinant immunoblot (IB) as the reference method. A panel of 137 serum samples with low or undetectable IgG levels was analyzed. Sensitivity ranged from 19.6% to 70.1%, while specificity exceeded 94%. Only 18.6% of immunoblot-positive samples tested positive across all assays. Marked quantitative differences were observed, with the Atellica assay yielding the highest titers and Alinity the lowest. Reclassifying equivocal </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-15T03:19:59.108Z</modification><creation>2026-06-15T03:11:21.521Z</creation></dates><accession>S-EPMC12844522</accession><cross_references><pubmed>41597578</pubmed><doi>10.3390/microorganisms14010058</doi></cross_references></HashMap>